Clinical Trial Update: N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) [Phase 2]

View source ↗

Summary

Phase 2 trial update for N-Acetyl-L-Leucine in Niemann-Pick Disease, Type C (NPC) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• N-Acetyl-L-Leucine (N-acetyl-L-leucine)

Snippet

Sponsor: IntraBio Inc | Conditions: Niemann-Pick Disease, Type C | Phase 2 | Status: COMPLETED | Results posted: 2023-11-28